# NewcelX Ltd.

**Source:** https://www.startuphub.ai/startups/newcelx
**Profile type:** Startup

> NewcelX is a biopharmaceutical company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases, including Type 1 Diabetes and ALS.

## About

NewcelX is an innovative biopharmaceutical company focused on developing transformative stem-cell-derived therapies for Type 1 Diabetes and other serious diseases. The company leverages a human pluripotent stem cell (hPSC) technology platform for scalable cell expansion and precise differentiation, with its lead program, NCEL-101 (IsletRx), designed to restore functional insulin production. Additionally, NewcelX is developing treatments for neurodegenerative diseases like ALS with its AstroRx® and DOXA platforms.

## Key facts

- **Slug:** newcelx
- **Website:** https://newcelx.com
- **Location:** Zurich, Switzerland
- **Founded:** 2025-01-01
- **Employees:** 30
- **Operating status:** Active
- **Sectors / tags:** Biotech, MedTech, Cellular Agriculture, Drug Discovery, Clinical Trials, Genomics, Neurodegenerative Diseases, Diabetes Treatment, Stem Cell Therapy, Regenerative Medicine
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/newcelx
  - Twitter: https://x.com/newcelXltd
  - Facebook: https://www.facebook.com/NewcelX

## Frequently asked

### What does NewcelX Ltd. do?

NewcelX is an innovative biopharmaceutical company focused on developing transformative stem-cell-derived therapies for Type 1 Diabetes and other serious diseases. The company leverages a human pluripotent stem cell (hPSC) technology platform for scalable cell expansion and precise differentiation, with its lead program, NCEL-101 (IsletRx), designed to restore functional insulin production. Additionally, NewcelX is developing treatments for neurodegenerative diseases like ALS with its AstroRx® a…

### Is NewcelX Ltd. trustworthy and reputable?

StartupHub's Data Trust & Reputation score for NewcelX Ltd. is 74 out of 100, based on site security posture and privacy practices.

### What is NewcelX Ltd.'s revenue?

StartupHub estimates NewcelX Ltd.'s annual revenue at $2.3M (range $1.5M to $3.4M, 63% confidence), based on comparable companies in the sector.

### Where is NewcelX Ltd. headquartered?

NewcelX Ltd. is headquartered in Zurich, Switzerland.

### When was NewcelX Ltd. founded?

NewcelX Ltd. was founded in 2025.

### What industry does NewcelX Ltd. operate in?

NewcelX Ltd. operates in Biotech, MedTech, Cellular Agriculture, Drug Discovery, Clinical Trials, Genomics.

### How many employees does NewcelX Ltd. have?

NewcelX Ltd. has approximately 30 people on record.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "NewcelX Ltd.",
          "item": "https://www.startuphub.ai/startups/newcelx"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/newcelx#webpage",
      "url": "https://www.startuphub.ai/startups/newcelx",
      "name": "NewcelX Ltd. - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of NewcelX Ltd.. NewcelX Ltd. is a startup founded in 2025, operating in Biotech and MedTech. NewcelX is a biopharmaceutical company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases, including Type 1 Diabetes and ALS. Headquartered in Zurich, Switzerland. The company has approximately 30 employees.",
      "dateModified": "2026-08-25T05:07:34.609+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/newcelx#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/newcelx#organization",
      "name": "NewcelX Ltd.",
      "url": "https://newcelx.com",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/fdae5db6-72ab-4db4-988d-2961e276e69a-square.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/fdae5db6-72ab-4db4-988d-2961e276e69a-square.webp",
      "description": "This is the official profile of NewcelX Ltd.. NewcelX Ltd. is a startup founded in 2025, operating in Biotech and MedTech. NewcelX is a biopharmaceutical company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases, including Type 1 Diabetes and ALS. Headquartered in Zurich, Switzerland. The company has approximately 30 employees.",
      "sameAs": [
        "https://www.linkedin.com/company/newcelx",
        "https://x.com/newcelXltd",
        "https://www.facebook.com/NewcelX",
        "https://www.startuphub.ai/startups/newcelx"
      ],
      "foundingDate": "2025-01-01",
      "numberOfEmployees": {
        "@type": "QuantitativeValue",
        "value": 30
      },
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Zurich",
        "addressCountry": "Switzerland"
      },
      "knowsAbout": [
        "Biotech",
        "MedTech",
        "Cellular Agriculture",
        "Drug Discovery",
        "Clinical Trials",
        "Genomics",
        "Neurodegenerative Diseases",
        "Diabetes Treatment",
        "Stem Cell Therapy",
        "Regenerative Medicine"
      ]
    }
  ]
}
```